|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
A prospective, open and randomized, two-way crossover study was conducted to evaluate the pharmacokinetics and bioavailability of oral fludarabine phosphate when taken on a full versus an empty stomach. The effectiveness of therapy was also assessed after two cycles of treatment, four weeks apart
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1466-4860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
316-21
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11920267-Administration, Oral,
pubmed-meshheading:11920267-Adult,
pubmed-meshheading:11920267-Aged,
pubmed-meshheading:11920267-Antimetabolites, Antineoplastic,
pubmed-meshheading:11920267-Area Under Curve,
pubmed-meshheading:11920267-Biological Availability,
pubmed-meshheading:11920267-Cross-Over Studies,
pubmed-meshheading:11920267-Female,
pubmed-meshheading:11920267-Food-Drug Interactions,
pubmed-meshheading:11920267-Humans,
pubmed-meshheading:11920267-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:11920267-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11920267-Male,
pubmed-meshheading:11920267-Middle Aged,
pubmed-meshheading:11920267-Prospective Studies,
pubmed-meshheading:11920267-Treatment Outcome,
pubmed-meshheading:11920267-Vidarabine Phosphate
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The bioavailability of oral fludarabine phosphate is unaffected by food.
|
|
pubmed:affiliation |
Royal Bournemouth Hospital, Bournemouth, UK. david.oscier@lineone.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
